Akut limfoid leukémia (ALL): vizsgálatok itt: Franciaország
40 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in FranciaországRole of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.
- Where
- Marseille, Nice
- Életkor
- 1 év to 99 év
- People
- 20
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07529223 - 3. fázisNot yet taking people in FranciaországPREV-CART - “A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiotic prophylaxis (AP) in patients treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B cell acute lymphoblastic leukemia or a B cell lymphoma”
- Where
- Angers, Brest, Caen, Clermont-Ferrand, Grenoble Cedex 9, Lille Cedex, Limoges Cedex 1, Nantes, Nice, Paris, Pessac, Saint-Priest-en-Jarez, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy
- People
- 228
- Run by
- Assistance Publique Hopitaux De Paris
See details and how to join2025-521571-30-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Angers, Bobigny, Le Mans, Lille, Limoges, Lyon, Marseille, Nantes, Nice, Paris, Talence, Villejuif
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2. fázisBefejeződöttInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Besancon Cedex, Bordeaux, Caen Cedex 9, Grenoble Cedex 9, Lille Cedex, Marseille, Nantes, Nice, Paris, Poitiers, Reims Cedex, Rennes, Rouen Cedex, Strasbourg Cedex 2, Toulouse Cedex 9
- Életkor
- Up to 17 év
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - No phaseTaking peopleStudy of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring
- Where
- Metz
- Életkor
- 1 év to 18 év
- People
- 50
- Run by
- Centre Hospitalier Régional Metz-Thionville
See details and how to joinNCT06867289 - 2/3. fázisTaking peopleA 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia
- Where
- Paris
- Életkor
- 18 év to 65 év
- People
- 1200
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06860269 - No phaseTaking peopleChildhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse
- Where
- Angers, Brest, Rennes
- Életkor
- 0 év to 17 év
- People
- 50
- Run by
- Rennes University Hospital
See details and how to joinNCT06649253 - No phaseTaking peopleStudy of the Medullary Microenvironment in Acute Childhood Leukemia
- Where
- Tours
- Életkor
- 1 év to 15 év
- People
- 40
- Run by
- University Hospital, Tours
See details and how to joinNCT05792007 - 1/2. fázisNot yet taking people in FranciaországHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
- Where
- Bordeaux, Lille Cedex, Lyon, Marseille, Nantes, Paris
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00 - 1/2. fázisNot yet taking people in FranciaországHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Bordeaux, Lille Cedex, Lyon, Marseille, Nantes, Paris
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01 - 1/2. fázisNot yet taking people in FranciaországHEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Bordeaux, Lille Cedex, Lyon, Marseille, Nantes, Paris
- Életkor
- 1 év to 21 év
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00 - No phaseTaking peopleEarly Assessment of Cardiac Function After Treatment With CAR-T Cells
- Where
- Paris
- Életkor
- 18 év and over
- People
- 60
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06350994 - 2. fázisTaking peopleGRAALL2014
- Where
- Amiens, Angers, Argenteuil Cedex, Avignon, Bayonne, Besançon, Bobigny, Brest, Caen, Clermont-Ferrand, Colmar Cedex, Corbeil Essonnes Cedex, Creteil Cedex, Dijon, Grenoble Cedex 9, Le Chesnay Rocquencourt, Lens, Lille Cedex, Limoges, Lyon, Marseille, Montpellier Cedex 5, Mulhouse, Nantes, Nice, Nice Cedex 2, Nimes Cedex 9, Orleans Cedex 2, Paris, Perpignan Cedex, Pessac Cedex, Pierre-Bénite, Poitiers, Pringy Cedex, Reims Cedex, Rennes, Roubaix, Rouen, Saint-Cloud, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Valenciennes, Vandoeuvre Les Nancy Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 1506 worldwide
- Run by
- Assistance Publique Hopitaux De Paris
See details and how to joinNCT02617004 · EU 2024-516103-16-00 - 1/2. fázisFut, nem toborozCombination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence
- Where
- Bordeaux, Bron, Lille Cedex, Lyon, Marseille, Montpellier Cedex 5, Nantes, Paris, Pierre-Bénite, Rouen Cedex, Strasbourg Cedex 2, Vandoeuvre Les Nancy Cedex
- Életkor
- 1 év to 25 év
- People
- 26
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05310591 · EU 2024-514345-11-00 - No phaseTaking peopleThe Patient Cohort of the National Center for Precision Medicine in Leukemia
- Where
- Bobigny, Paris
- People
- 3000
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05326919